Stock BCLI BRAINSTORM CELL THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Brainstorm Cell Therapeutics Inc.

Equities

BCLI

US10501E2019

Market Closed - Nasdaq
Other stock markets
 21:00:00 26/04/2024 BST 		5-day change 1st Jan Change
0.5345 USD +0.47% Intraday chart for Brainstorm Cell Therapeutics Inc. +0.47% +95.79%
04-17 Brainstorm Cell Therapeutics Inc. Announces Step Down of Stacy Lindborg as Co-CEO, Effective as of May 9, 2024 CI
04-17 Brainstorm Cell Therapeutics Inc. Announces Management Changes CI

Chart calendar Brainstorm Cell Therapeutics Inc.

a2f0da92197b86543f9c0.lDYXyAzzMSjScnwAMktHoxK601euTJmH-gK1_u6vzfE.3Xpen124XGqgERR2dSwg-VuOuQLbCtHvlXTyt6fYvsPxWXCjX58FTaU4NQ~7059661bd2a164fb0694cfe32fe93acd

Upcoming events on Brainstorm Cell Therapeutics Inc.

09/05/2024 Q1 2024 Earnings Release (Projected)
11/08/2024 Q2 2024 Earnings Release (Projected)
10/11/2024 Q3 2024 Earnings Release (Projected)
26/03/2025 Q4 2024 Earnings Release (Projected)

Past events on Brainstorm Cell Therapeutics Inc.

09/04/2024 13:00 Business Update Call
01/04/2024 13:05 Q4 2023 Earnings Release
05/03/2024 European Life Sciences CEO Forum
04/03/2024 23:00 MDA Clinical and Scientific Conference
28/02/2024 16:20 European Life Sciences CEO Forum
28/02/2024 12:40 European Life Sciences CEO Forum
17/12/2023 Annual General Meeting
14/11/2023 13:30 Q3 2023 Earnings Call
14/11/2023 12:05 Q3 2023 Earnings Release
18/10/2023 13:30 Business Update Call
26/09/2023 ADCOM Conference
14/08/2023 13:00 Q2 2023 Earnings Call
14/08/2023 12:05 Q2 2023 Earnings Release
05/07/2023 17:00 Gordon Research Conference
21/06/2023 14:00 Maxim Group Virtual Healthcare Conference
15/05/2023 13:00 Q1 2023 Earnings Call
15/05/2023 12:05 Q1 2023 Earnings Release
30/03/2023 13:00 Q4 2022 Earnings Call
30/03/2023 12:05 Q4 2022 Earnings Release
27/03/2023 13:00 Business Update Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-23,0
-20,4
-13%		-31,7
-26,3
-20.41%		-24,5
-29,0
15.32%		-24,8
-25,9
4.18%		-21,4
-25,3
15.2%
-21,9

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-23,3
-20,5
-13.33%		-31,8
-26,1
-21.82%		-24,5
-28,7
14.93%		-24,3
-25,5
4.66%		-17,2
-25,2
31.71%
-21,9

Net income
Million USD		Released
Forecast
Spread 		-23,3
-20,2
-15.39%		-31,8
-26,1
-21.82%		-24,5
-28,7
14.93%		-24,3
-25,5
4.66%		-17,2
-23,0
25.37%
-21,9

EPS
USD		Released
Forecast
Spread 		-1,06
-0,91
-17.13%		-1,07
-0,89
-20.22%		-0,68
-0,79
13.92%		-0,66
-0,68
2.22%		-0,40
-0,56
28.57%
-0,28

Announcement Date18/02/2004/02/2128/03/2230/03/2301/04/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-6,21
-7,17
13.3%		-5,48
-4,70
-16.49%		-7,59
-5,46
-39.14%		-6,84
-6,75
-1.39%		-4,92
-6,00
18.08%		-5,15
-6,01
14.24%		-5,45
-5,70
4.43%		-6,04
-6,00
-0.56%		-4,80
-6,33
24.1%
-4,50


-5,20


-5,80


-6,40

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-6,19
-7,17
13.61%		-5,36
-4,70
-14.04%		-7,04
-5,46
-29.06%		-6,86
-6,75
-1.65%		-5,02
-6,00
16.37%		-5,06
-5,96
15.06%		-5,33
-5,65
5.71%		-1,23
-6,00
79.57%		-5,58
-6,33
11.87%
-4,50


-5,20


-5,80


-6,40

Net income
Million USD		Released
Forecast
Spread 		-6,19
-7,17
13.61%		-5,36
-4,70
-14.04%		-7,04
-5,46
-29.06%		-6,86
-6,75
-1.65%		-5,02
-6,00
16.37%		-5,06
-5,96
15.06%		-5,33
-5,65
5.71%		-1,23
-6,00
79.57%		-5,58
-6,33
11.87%
-4,50


-5,20


-5,80


-6,40

EPS
USD		Released
Forecast
Spread 		-0,17
-0,20
12.82%		-0,15
-0,13
-15.38%		-0,19
-0,15
-31.03%		-0,19
-0,18
-5.56%		-0,13
-0,15
10.34%		-0,14
-0,17
15.15%		-0,13
-0,15
10.34%		-0,03
-0,15
79.31%		-0,11
-0,13
15.38%
-0,07


-0,07


-0,06


-0,07

Announcement Date28/03/2216/05/2215/08/2214/11/2230/03/2315/05/2314/08/2314/11/2301/04/24----

Upcoming sector events for Brainstorm Cell Therapeutics Inc.

28/04/2024 BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected)
28/04/2024 SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release
28/04/2024 JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release
28/04/2024 MORPHOSYS AG: Q1 2024 Earnings Release
29/04/2024 21:05 QIAGEN N.V.: Q1 2024 Earnings Release
29/04/2024 CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected)
30/04/2024 DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 AZENTA, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Brainstorm Cell Therapeutics Inc.

Today GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release
Today GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release
26/04/2024 06:00 BB BIOTECH AG: Q1 2024 Earnings Release
25/04/2024 BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release
25/04/2024 PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release
25/04/2024 HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected)
25/04/2024 BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release
25/04/2024 CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release
25/04/2024 12:00 MORPHIC HOLDING, INC.: Q1 2024 Earnings Release
25/04/2024 07:00 PURETECH HEALTH PLC: Q4 2023 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BCLI Stock
  4. Calendar Brainstorm Cell Therapeutics Inc.